Business Description
Trellus Health PLC
ISIN : GB00BNNFM402
Share Class Description:
LSE:TRLS: Ordinary SharesTotal Employee Number:
18Compare
Compare
Traded in other countries / regions
TRLS.UK85Q.Germany IPO Date
2021-05-28Description
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.94 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -4.05 | |||||
Beneish M-Score | 2.22 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -1 | |||||
3-Year FCF Growth Rate | 7.5 | |||||
3-Year Book Growth Rate | -29.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 60.98 | |||||
9-Day RSI | 55.86 | |||||
14-Day RSI | 53.62 | |||||
6-1 Month Momentum % | -81.54 | |||||
12-1 Month Momentum % | -85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.63 | |||||
Quick Ratio | 3.63 | |||||
Cash Ratio | 3.06 | |||||
Days Sales Outstanding | 189.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -2001.87 | |||||
Net Margin % | -1972.76 | |||||
EBITDA Margin % | -1751.12 | |||||
FCF Margin % | -1849.25 | |||||
OCF Margin % | -1766.79 | |||||
ROE % | -56.66 | |||||
ROA % | -54.46 | |||||
ROIC % | -89.86 | |||||
3-Year ROIIC % | -75.98 | |||||
ROC (Joel Greenblatt) % | -50296.88 | |||||
ROCE % | -57.49 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.2 | |||||
PB Ratio | 0.03 | |||||
Price-to-Tangible-Book | 0.12 | |||||
EV-to-EBIT | 0.12 | |||||
EV-to-EBITDA | 0.14 | |||||
EV-to-Revenue | -2.4 | |||||
EV-to-FCF | 0.13 | |||||
| Price-to-Net-Current-Asset-Value | 0.12 | |||||
| Price-to-Net-Cash | 0.06 | |||||
Earnings Yield (Greenblatt) % | 828.13 | |||||
FCF Yield % | -960.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Trellus Health PLC Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 0.268 | ||
| EPS (TTM) (£) | -0.039 | ||
| Beta | 9.6683 | ||
| 3-Year Sharpe Ratio | 0.08 | ||
| 3-Year Sortino Ratio | 0.25 | ||
| Volatility % | 185.02 | ||
| 14-Day RSI | 53.62 | ||
| 14-Day ATR (£) | 0.00009 | ||
| 20-Day SMA (£) | 0.00112 | ||
| 12-1 Month Momentum % | -85 | ||
| 52-Week Range (£) | 0.0004 - 0.02336 | ||
| Shares Outstanding (Mil) | 430.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Trellus Health PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Trellus Health PLC Stock Events
| Event | Date | Price (£) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-09-08 | In 6 days | ||
| General meeting for 2026 | 2026-06-30 13:00 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-06-04 | 0.00 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-06-03 11:00 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-06-02 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-09-08 | 0.01 (+0.00%) | ||
| General meeting for 2025 | 2025-06-30 13:00 | 0.01 (+0.00%) | ||
| Annual report for 2024 | 2025-06-04 | 0.01 (+0.00%) | ||
| Fourth quarter earnings conference call for 2024 | 2025-06-03 11:00 | 0.01 (-38.89%) | ||
| Fourth quarter earnings results for 2024 | 2025-06-02 | 0.02 (+0.00%) |
Show
Entries
Trellus Health PLC Frequently Asked Questions
What is Trellus Health PLC(LSE:TRLS)'s stock price today?
The current price of LSE:TRLS is £0.00. The 52 week high of LSE:TRLS is £0.02 and 52 week low is £0.00.
When is next earnings date of Trellus Health PLC(LSE:TRLS)?
The next earnings date of Trellus Health PLC(LSE:TRLS) is 2026-09-08 Est..
Does Trellus Health PLC(LSE:TRLS) pay dividends? If so, how much?
Trellus Health PLC(LSE:TRLS) does not pay dividend.
Press Release
Articles on Trellus Health PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers